Detalles de la búsqueda
1.
Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
J Am Coll Cardiol;
2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597864
2.
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Cardiovasc Diabetol;
23(1): 49, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302936
3.
Understanding the patient experience of Classic Galactosemia in pediatric and adult patients: increased disease burden, challenges with daily living, and how they evolve over time.
J Patient Rep Outcomes;
7(1): 95, 2023 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751006
4.
Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency.
JCI Insight;
8(10)2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37014713
5.
Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation.
Cardiovasc Diabetol;
22(1): 73, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978133
6.
Rationale and design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in patients with high-risk diabetic cardiomyopathy.
Am Heart J;
256: 25-36, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372245
7.
Qualitative interviews with adults with Classic Galactosemia and their caregivers: disease burden and challenges with daily living.
Orphanet J Rare Dis;
17(1): 138, 2022 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35346295
8.
A pilot open-label study of aldose reductase inhibition with AT-001 (caficrestat) in patients hospitalized for COVID-19 infection: Results from a registry-based matched-control analysis.
Diabetes Metab Syndr;
15(6): 102328, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34752935
9.
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes.
Diabetes Ther;
11(6): 1293-1302, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304086
10.
The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting.
Diabetes Obes Metab;
21(6): 1429-1436, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30768845
11.
Propensity-score-matched comparative analyses of simultaneously administered fixed-ratio insulin glargine 100 U and lixisenatide (iGlarLixi) vs sequential administration of insulin glargine and lixisenatide in uncontrolled type 2 diabetes.
Diabetes Obes Metab;
20(12): 2821-2829, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29974618
12.
Comment on: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes.
BioDrugs;
32(2): 177, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29546566
13.
Safety of Degludec versus Glargine in Type 2 Diabetes.
N Engl J Med;
377(20): 1995, 2017 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29143515
14.
Lixisenatide Therapy in Older Patients With Type 2 Diabetes Inadequately Controlled on Their Current Antidiabetic Treatment: The GetGoal-O Randomized Trial.
Diabetes Care;
40(4): 485-493, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188240
15.
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.
Cardiovasc Diabetol;
16(1): 6, 2017 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28086882
16.
Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial.
Diabetes Care;
39(9): 1579-86, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27284114
17.
A patient-centric approach to optimise insulin therapy in Asia.
J Diabetes Complications;
30(6): 973-80, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27288201
18.
Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial.
Diabetes Care;
39(8): 1318-28, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27222510
19.
Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study.
Endocr Pract;
21(2): 143-57, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25297660
20.
Once-daily prandial lixisenatide versus once-daily rapid-acting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal insulin: analysis of data from five randomized, controlled trials.
J Diabetes Complications;
28(1): 40-4, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246441